FOR: CARDIOCOMM SOLUTIONS, INC.
TSX VENTURE SYMBOL: EKG

CARDIOCOMM SOLUTIONS IS LISTED BY THE FAA CIVIL AEROSPACE MEDICAL INSTITUTE AS AN ECG CLOUD SERVICES PROVIDER FOR USE BY AIR MEDICAL EXAMINERS

ECG Modernization Project Links CardioComm Solutions to the FAA Aviation Medical Examiner (AME) Community

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed that it has been listed as a cloud services provider under the launch of the Federal Aviation Administration (“FAA”) Civil Aerospace Medical Institute ECG Modernization project. The specific product involved is the Company’s GlobalCardio™ 12 Lead ECG solution (“GC12”).

“During the fall of 2013, the Aerospace Medical Certification Division, in partnership with FAA's Office of Information Technology, began working to replace the existing FAA ECG system. CardioComm Solutions was informed in late June 2014 of the decision by the FAA to be listed as a cloud-based ECG service provider under their initiative for the digital modernization of their existing system. The listing of our Company, as well as those of ECG equipment providers, is not an endorsement by the FAA. That being said, we did undergo a review by the FAA IT Support Group and our 12 lead solution remains the only one identified as a cloud-based, virtual ECG service to render ECG reports in a PDF format for their Airman Medical Certification Subsystem (“AMCS”) workstations,” said Simi Grosman, member of the Company’s Board.

The GC12 solution is an FDA cleared, Health Canada approved and CE marked technology and ECG service and has also been used in multiple clinical trials. “Due to GC12’s global regulatory approvals and adherence to PIPEDA and HIPPA requirements, this is a logical offering to FAA AMEs regardless of their geographic distribution. The system offers a cost effective solution that can be used in busy clinics and in mobile applications, and can provide a per ECG, fixed purchase cost or annual licensing option, depending on the business needs of the AME,” said Etienne Grima, Chief Executive Officer for CardioComm Solutions. “With our capacity to integrate our software with several ECG device manufacturer 12 lead ECG machines, the GC12 offering will provide needed flexibility for AMEs to move into compliance with the FAA directed changes related to the recording and uploading of ECG reports into their proprietary medical records system.”

The ECG Modernization FAA website lists over 3,200 AMEs registered through the FAA globally who act as representatives of the FAA Administrator and are authorized by law to examine, test and/or make inspections necessary to issue airman or aircraft certificates. The new system was released August 27 and AMEs will have until September 30 to make the transition, after which date the current ECG system will be deactivated permanently.

“This listing marks a material opportunity as it introduces CardioComm Solutions into a highly regulated environment. The FAA Civil Aerospace Medical Institute (“CAMI”) is the medical certification, research, education and occupational health wing of the FAA's Office of Aerospace Medicine whose goal is to enhance aviation safety. This is but one of several phases of our planned market entry strategy for the US government and defense agencies,” closed Etienne Grima.

More information regarding the HeartCheck™ products and SMART Monitoring solutions is available at the Company’s web site www.cardiocommsolutions.com.

download pdf

About CardioComm Solutions
CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients.  Products are sold worldwide through a combination of an external distribution network and a North American-based sales team.  The Company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices.  CardioComm Solutions is headquartered in Toronto, Canada, with offices in Victoria, B.C.  

FOR FURTHER INFORMATION PLEASE CONTACT:

Etienne Grima, Chief Executive Officer
1-877-977-9425
investorrelations@cardiocommsolutions.com
www.cardiocommsolutions.com

Forward-looking statements

This release may contain certain forward-looking statements and forward looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management's current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.

In evaluating these statements, readers should: specifically consider risks discussed under the heading "Risk Factors" in the Company's Annual Information Form, available at www.sedar.com; not to place undue reliance on forward-looking statements and forward-looking information; be aware. the Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this Annual Information Form other than as required by applicable laws (including without limitation Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.